Search results for: stress disorder adaptive platform

The Department of Defense (DOD) is funding and has established this posttraumatic stress disorder (PTSD) adaptive platform trial (APT). The team is now seeking interested partners to serve as the regulatory sponsor and holder of the existing Master Protocol Investigational New Drug (IND) application to the U.S.

The Medical Technology Enterprise Consortium (MTEC) is excited to post this announcement for a Request for Project Proposals (RPP) to support the development and maintenance of clinical trial infrastructure for the simultaneous and sequential testing of drug interventions to treat post-traumatic stress disorder (PTSD) in an adaptive platform trial (APT) design. Scope of Work: The DOD has identified three focus areas for funding under this RPP.